Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Pennsylvania, United States
Countries of investment
  • USA
Investment stages
  • Seed
  • Series A
Industries
  • Manufacturing
  • Pharmaceuticals
  • Diagnostics
  • Biotechnology
  • Medical Devices
  • Digital Health
About
BioAdvance is a venture capital firm that invests in therapies, medical devices, research tools, diagnostics, and health IT in the Mid Atlantic region. They collaborate with entrepreneurs to develop strong companies focused on enhancing human health.
Min check size
$500K
Max check size
$1M
Fund size
NPS

Investment Thesis

BioAdvance focuses on providing earlystage capital to companies developing technologies to improve human health. Their investments emphasize therapeutic agents, platform technologies, research tools, medical devices, diagnostics, and healthcare IT.
Lead investor
Co Invest
Number of exits
Preferred contact method

BioAdvance Contacts Information

Primary contact

Secondary contact

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp